ArticleFrontiers in pharmacology2018

Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial.

Arnauld Verschuur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.